1. Home
  2. RFL vs UAMY Comparison

RFL vs UAMY Comparison

Compare RFL & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • UAMY
  • Stock Information
  • Founded
  • RFL 2017
  • UAMY 1968
  • Country
  • RFL United States
  • UAMY United States
  • Employees
  • RFL N/A
  • UAMY N/A
  • Industry
  • RFL Real Estate
  • UAMY Metal Fabrications
  • Sector
  • RFL Finance
  • UAMY Industrials
  • Exchange
  • RFL Nasdaq
  • UAMY Nasdaq
  • Market Cap
  • RFL 48.4M
  • UAMY 251.9M
  • IPO Year
  • RFL N/A
  • UAMY N/A
  • Fundamental
  • Price
  • RFL $1.84
  • UAMY $2.22
  • Analyst Decision
  • RFL
  • UAMY Strong Buy
  • Analyst Count
  • RFL 0
  • UAMY 4
  • Target Price
  • RFL N/A
  • UAMY $3.38
  • AVG Volume (30 Days)
  • RFL 465.0K
  • UAMY 5.3M
  • Earning Date
  • RFL 06-11-2025
  • UAMY 08-08-2025
  • Dividend Yield
  • RFL N/A
  • UAMY N/A
  • EPS Growth
  • RFL N/A
  • UAMY N/A
  • EPS
  • RFL N/A
  • UAMY N/A
  • Revenue
  • RFL $732,000.00
  • UAMY $18,865,900.00
  • Revenue This Year
  • RFL N/A
  • UAMY $270.45
  • Revenue Next Year
  • RFL N/A
  • UAMY $104.06
  • P/E Ratio
  • RFL N/A
  • UAMY N/A
  • Revenue Growth
  • RFL 35.56
  • UAMY 97.46
  • 52 Week Low
  • RFL $1.27
  • UAMY $0.27
  • 52 Week High
  • RFL $3.19
  • UAMY $3.86
  • Technical
  • Relative Strength Index (RSI)
  • RFL 54.72
  • UAMY 39.44
  • Support Level
  • RFL $1.56
  • UAMY $2.71
  • Resistance Level
  • RFL $2.04
  • UAMY $2.71
  • Average True Range (ATR)
  • RFL 0.16
  • UAMY 0.24
  • MACD
  • RFL -0.00
  • UAMY -0.07
  • Stochastic Oscillator
  • RFL 61.54
  • UAMY 24.14

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

Share on Social Networks: